Search

everythinglearnresearchcommunity

for

Search:↓

Both baricitinib and tofacitinib effectively reduce alopecia areata severity, with tofacitinib showing more improvement over longer use.

Tofacitinib significantly improved skin and hair conditions without side effects.

Tofacitinib helped a woman regrow hair with no major side effects.

Tofacitinib 2% ointment helped hair regrow in 3 out of 10 patients with alopecia areata, but caused side effects like scalp irritation and raised cholesterol in some.

Tofacitinib may effectively regrow hair in alopecia totalis patients.

Tofacitinib is a safe and effective treatment for hair loss in children with Alopecia Areata.

Standard dosing is more effective for severe alopecia areata in children, but unorthodox dosing can be safe and considered if needed.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Tofacitinib helped a woman regrow her hair without relapses after other treatments failed.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Tangent screens help detect visual field defects from vigabatrin.

Bicalutamide does not significantly affect liver enzymes and is a safe anti-androgen option for transfeminine individuals.

Tofacitinib helped a teenager with severe hair loss grow hair back, but more research is needed.

A woman with severe hair loss saw significant hair regrowth after adding platelet-rich plasma injections to her treatment with tofacitinib.

Tofacitinib was effective for severe, treatment-resistant hair loss without side effects.

Oral tofacitinib may be an effective and tolerable treatment for some people with severe alopecia areata.

A woman's total hair loss from hepatitis C treatment grew back after stopping the medication.

Lenvatinib and sorafenib are generally safe but need dose adjustments due to side effects.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Some skin medications can have harmful interactions with the COVID-19 drug nirmatrelvir-ritonavir, but not with molnupiravir.

Sorafenib often causes mucositis, hand-foot syndrome, rash, alopecia, diarrhea, and fatigue.

A man with HIV developed skin and hair issues after starting HIV treatment, which improved with topical treatment.

Low-dose sorafenib can cause severe facial acne, treatable with topical medication.

Tofacitinib may help regrow hair in alopecia areata patients.

Tofacitinib helped most patients with alopecia areata regrow hair and changes in immune cells were linked to the treatment's effectiveness.

A woman developed Cushing syndrome and adrenal insufficiency from using fluticasone and ritonavir together.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Tofacitinib may effectively treat skin symptoms in difficult cases of dermatomyositis.

Indinavir and ritonavir therapy can cause reversible hair loss.